Research Article

Prevalence of E. coli ST131 among Uropathogenic E. coli Isolates from Iraqi Patients in Wasit Province, Iraq

Table 6

Antimicrobial resistance of 17 E. coli ST131 isolates.

Class of antimicrobial agentAntimicrobial agentNo. (%) of resistant E. coli ST131 isolates

β-LactamsAMP17 (100): R = 17, I = 0
AMC15 (88.2): R = 12, I = 3
FOX13 (76.4): R = 7, I = 6
CTX12 (70.5): R = 10, I = 2
CAZ13 (76.4): R = 10, I = 3
CRO9 (52.9): R = 9, I = 0
FEP14 (82.3): R = 9, I = 5
ATM10 (58.8): R = 7, I = 3
IPM0
MEM0
AminoglycosidesCN3 (17.6): R = 2, I = 1
AK1 (5.8): R = 0, I = 1
TetracyclinesTE13 (76.4): R = 10, I = 3
FluoroquinoloneNA7 (41.1): R = 7, I = 0
CIP6 (35.2): R = 5, I = 1
TrimethoprimSXT8 (47.0): R = 8, I = 0
NitrofuransF1 (5.8): R = 1, I = 0
Multidrug resistance (MDR)9 (52.9)

R: resistant; I: intermediate.